Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bromocriptine in Parkinson disease.

A N Lieberman, M Goldstein

    Pharmacological Reviews
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Bromocriptine effectively treats Parkinson's disease, especially when combined with levodopa. Higher doses are needed for advanced stages, but combination therapy improves efficacy with manageable side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Point of view: Dementia in Parkinson's disease.

    Parkinsonism & related disorders·2008
    Same author

    Prevalence of tremor and Parkinson's disease.

    Parkinsonism & related disorders·1996
    Same author

    Transient resolution of bilateral tremor after unilateral thalamotomy, associated with focal injury of the corpus callosum: case report.

    Journal of the neurological sciences·1995
    Same author

    Novel heuristics of functional neural networks: implications for future strategies in functional neurosurgery.

    Stereotactic and functional neurosurgery·1995
    Same author

    Temporal dissociation of the prehension pattern in Parkinson's disease.

    Neuropsychologia·1993
    Same author

    Site-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysis.

    The Journal of biological chemistry·1992

    Area of Science:

    • Neuroscience
    • Pharmacology

    Background:

    • Bromocriptine is a dopamine agonist with unique mixed agonist-antagonist properties.
    • It interacts with D2 dopamine receptors without differentiating between high and low affinity states.

    Purpose of the Study:

    • To evaluate the efficacy of bromocriptine, alone and with levodopa, in Parkinson's disease patients.
    • To compare low-dose and high-dose bromocriptine regimens.

    Main Methods:

    • Systematic review of 27 studies involving 790 Parkinson's disease patients.
    • Analysis of bromocriptine efficacy and adverse effects in various dosages and combinations with levodopa.

    Main Results:

    • Bromocriptine alone showed improvement in 58-62% of patients, with fewer side effects at lower doses.

    Related Experiment Videos

  • Combination therapy with levodopa improved efficacy (58-71%) but increased adverse effects, particularly in advanced disease.
  • Bromocriptine alone did not cause diurnal oscillations, unlike combination therapy in advanced cases.

    • Conclusions:

    • Bromocriptine is effective for Parkinson's disease, with enhanced efficacy when combined with levodopa.
    • Dosage and combination therapy should be tailored to disease severity and patient response.
    • Bromocriptine's unique receptor interaction may contribute to its therapeutic profile.